President Donald Trump is rumoured to be resurrecting a policy proposed in his first term that would see drug prices offered to federal programmes tied to those offered overseas. According to ...

Pfizer has partnered with a ‘computation-driven’ pharmaceutical technology company to develop a drug discovery platform powered by artificial intelligence (AI). Its collaboration with ...

In recent years, pharma companies have invested heavily in their healthcare provider (HCP) portals, along with other digital solutions, to account for the reduction in face-to-face time between ...

It is important to empower new entrants into the business. With businesses looking to build up talent pipelines and a rise in employer demand predicted, entrusting new talent with responsibility ...

Delivery by drone is often talked about in the retail sector – to make delivery of consumer goods quicker and with greater convenience. However, Ben Hargreaves finds that the advantages for ...

Shares in PolyPid have been under pressure after the Israeli biotech reported its antibiotic for surgical site infections failed a phase 3 trial, although there may still be a way forward for the ...

In this article, we present a framework designed to evaluate the progress and impact of AI tools across various use cases in drug discovery. This framework helps organisations better understand ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

With information overload, rapidly and effectively communicating complex medical data to healthcare professionals, researchers, and patients is crucial. Today’s audiences not only benefit from ...

Whether we’re marketing a pharmaceutical brand, diagnostic, device, or medtech product, the need for an omnichannel strategy can’t be ignored. As consumers, when we’re buying our weekly ...

Viatris has made a play to expand its branded medicines business by licensing two late-stage drugs from Idorsia – for acute myocardial infarction (AMI) and systemic lupus erythematosus (SLE ...

The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors. Lawmakers ...